mezlocillin has been researched along with cefotaxime in 50 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 38 (76.00) | 18.7374 |
1990's | 8 (16.00) | 18.2507 |
2000's | 3 (6.00) | 29.6817 |
2010's | 1 (2.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
Bauernfeind, A; Grimm, H; Klietmann, W; Opferkuch, W; Werner, H | 1 |
Barrett, MS; Erwin, ME; Johnson, DM; Jones, RN | 1 |
Acar, JF; Denis, F; Drugeon, H; Fleurette, J; Kazmierczak, A; Siebor, E; Sirot, J; Soussy, CJ; Thabaut, A | 1 |
Heizmann, WR; Manncke, K; Sonntag, HG; Springsklee, M | 1 |
Maier, H; Schlegel, P; Zerfowski, M | 1 |
Parry, MF | 1 |
Schmalreck, AF; Wildfeuer, A | 1 |
Chastagner, P; Flamant, F; Hartmann, O; Kalifa, C; Lemerle, J; Patte, C; Tancrede, C | 1 |
Barriere, SL; Flaherty, JF; Gambertoglio, JG; Rodondi, LC; Schoenfeld, P | 1 |
Eibel, G; Pfaff, G; Räder, K; Schmalreck, A; Wildfeuer, A | 1 |
Cole, DS; Rowe-Jones, DC | 1 |
Alkan, M; Berger, S; Mark, Z; Rubinstein, E; Samra, Y | 1 |
DiVincenzo, CA; O'Keefe, JP; Tatarowicz, W; Venezio, FR | 1 |
Baars, B; Cullmann, W; Opferkuch, W; Stieglitz, M | 1 |
Jeljaszewicz, J; Ko, HL; Pulverer, G; Roszkowski, K; Roszkowski, W; van der Waaij, D | 1 |
Barba, D; Esposito, S; Galante, D | 1 |
Sedallian, A | 1 |
Bouillet, L; Husson, MO; Izard, D; Leclerc, H | 1 |
Ashton, JJ; Brandt, JT; Copelan, EA; Fass, RJ; Moeschberger, ML | 1 |
Cheng, N; Chow, AW; Whiting, JL | 1 |
Malottke, R; Potel, J | 1 |
Focht, J; Heilmann, HD; Heinrich, S; Klietmann, W | 1 |
Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR | 1 |
Adams, CR; Anderson, EL; Robinson, PA; Tu, KK | 1 |
Hamelmann, H; Jostarndt, L; Thiede, A | 1 |
Jeljaszewicz, J; Ko, HL; Pulverer, G; Roszkowski, K; Roszkowski, W | 2 |
Childs, SJ; Mirelman, S; Wells, WG | 1 |
Bruch, HP; Döll, W; Kujath, P; Schmidt, E | 1 |
Goering, RV; Sanders, CC; Sanders, WE; Werner, V | 1 |
Baker, CN; Jones, RN; Thornsberry, C | 1 |
Aznar, J; Iglesias, MC; Martin, E; Nogales, MC; Perea, EJ | 1 |
Cordossis, T; Kosmidis, J; Lambropoulos, S; Melissinos, K; Tselentis, J | 1 |
Grimm, H | 1 |
LeFrock, JL; Miller, MA; Vercler, MJ | 1 |
Häfelein, J; Marklein, G | 1 |
Marklein, G | 1 |
Weinstein, AJ | 1 |
Labthavikul, P; Neu, HC | 1 |
Höffler, U; Niederau, W; Pape, W; Pulverer, G; Schaal, KP | 1 |
Traub, WH | 1 |
Neu, HC | 1 |
Daikos, GK; Kosmidis, J | 1 |
Monteil, H; Peladan, F; Zinsius, M | 1 |
Calderwood, SB; Jackson, E; Tung, CC | 1 |
Bernhardt, H; Knoke, M; Schulz, K; Zimmermann, K | 1 |
7 trial(s) available for mezlocillin and cefotaxime
Article | Year |
---|---|
[In vitro activity of beta-lactam antibiotics in combination with sulbactam against enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter. Results of a multicenter study].
Topics: Acinetobacter; Cefoperazone; Cefotaxime; Ceftazidime; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enterobacteriaceae; Humans; In Vitro Techniques; Mezlocillin; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Ticarcillin | 1991 |
[Sulbactam in combination with mezlocillin, piperacillin or cefotaxime. Clinical and bacteriological results in the treatment of severe bacterial infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefotaxime; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mezlocillin; Middle Aged; Piperacillin; Sulbactam | 1991 |
Influence of coadministration on the pharmacokinetics of mezlocillin and cefotaxime in healthy volunteers and in patients with renal failure.
Topics: Adult; Cefotaxime; Chromatography, High Pressure Liquid; Drug Interactions; Drug Therapy, Combination; Female; Half-Life; Humans; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Mezlocillin; Middle Aged; Random Allocation | 1989 |
[Interpretation of results of clinical studies for practical colon and rectum surgery].
Topics: Cefotaxime; Clinical Trials as Topic; Colonic Diseases; Fecal Incontinence; Humans; Intestinal Fistula; Mezlocillin; Premedication; Rectal Diseases; Surgical Staplers; Surgical Wound Dehiscence; Surgical Wound Infection; Suture Techniques; Urination Disorders; Wound Healing | 1985 |
Perioperative mezlocillin vs cefotaxime to prevent infections after genitourinary surgery.
Topics: Adult; Aged; Cefotaxime; Double-Blind Method; Female; Humans; Male; Mezlocillin; Middle Aged; Premedication; Prospective Studies; Random Allocation; Surgical Wound Infection; Urogenital System | 1985 |
[Perioperative prophylaxis in elective colorectal surgery].
Topics: Aged; Anti-Bacterial Agents; Cefmenoxime; Cefotaxime; Colonic Neoplasms; Combined Modality Therapy; Crohn Disease; Diverticulitis, Colonic; Humans; Intestinal Mucosa; Mezlocillin; Middle Aged; Moxalactam; Piperacillin; Premedication; Rectal Neoplasms; Surgical Wound Infection | 1984 |
Prospective randomized comparative studies of mezlocillin/cefotaxime vs. gentamicin/cefoxitin.
Topics: Adult; Aged; Bacterial Infections; Cefotaxime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Mezlocillin; Middle Aged; Random Allocation | 1983 |
43 other study(ies) available for mezlocillin and cefotaxime
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
[The effect of sulbactam on the in vitro activity of mezlocillin, piperacillin and cefotaxime].
Topics: Acinetobacter; Bacteria; Bacteroides; Cefotaxime; Drug Interactions; Enterobacteriaceae; Mezlocillin; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Staphylococcus; Sulbactam | 1991 |
Antimicrobial activity of isepamicin (SCH21420, 1-N-HAPA gentamicin B) combinations with cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, imipenem, mezlocillin and piperacillin tested against gentamicin-resistant and susceptible gram-negative bacilli
Topics: Cefotaxime; Ceftazidime; Culture Media; Drug Interactions; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enterococcus; Gentamicins; Gram-Negative Bacteria; Imipenem; Mezlocillin; Piperacillin; Pseudomonas | 1991 |
[Excretion of beta-lactam antibiotics in human parotid saliva].
Topics: Adult; Anti-Bacterial Agents; Cefotaxime; Cefotiam; Half-Life; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Mezlocillin; Microbial Sensitivity Tests; Oxacillin; Parotid Gland; Saliva | 1991 |
Aztreonam susceptibility testing. A retrospective analysis.
Topics: Ampicillin; Aztreonam; Bacteria; Cefotaxime; Ceftazidime; Gentamicins; Mezlocillin; Microbial Sensitivity Tests | 1990 |
In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
Topics: Ampicillin; beta-Lactamases; Cefotaxime; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Mezlocillin; Microbial Sensitivity Tests; Piperacillin; Sulbactam | 1990 |
Role of parenteral antibiotherapy in gastrointestinal tract flora suppression. A study in children treated with high-dose chemotherapy and autologous bone marrow transplantation.
Topics: Adolescent; Agranulocytosis; Bone Marrow Transplantation; Cefotaxime; Child; Child, Preschool; Digestive System; Dose-Response Relationship, Drug; Drug Combinations; Feces; Female; Gentamicins; Gram-Positive Bacteria; Humans; Infusions, Parenteral; Male; Mezlocillin; Moxalactam; Sulfamethizole; Suppression, Genetic; Tobramycin; Transplantation, Autologous; Trimethoprim | 1989 |
Studies on the synergism of sulbactam and beta-lactam antibiotics under in vitro conditions and in healthy volunteers after intravenous administration. Antibacterial activity in vitro, compatibility and pharmacokinetics of the drugs in combination.
Topics: Adult; Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefotaxime; Drug Synergism; Half-Life; Humans; Injections, Intravenous; Mezlocillin; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Sulbactam | 1989 |
Single dose mezlocillin versus three dose cefuroxime plus metronidazole for prophylaxis in large bowel surgery.
Topics: Cefotaxime; Colon; Drug Therapy, Combination; Humans; Infection Control; Metronidazole; Mezlocillin; Postoperative Complications | 1988 |
In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
Topics: Acinetobacter; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Azlocillin; Bacteria; Cefamandole; Cefotaxime; Cefsulodin; Ciprofloxacin; Citrobacter; Cloxacillin; Enterobacter; Escherichia coli; Gentamicins; Humans; Klebsiella pneumoniae; Mezlocillin; Penicillin Resistance; Proteus; Pseudomonas aeruginosa; Quinolines; Serratia marcescens; Shigella; Staphylococcus | 1986 |
Activity of ciprofloxacin against multiply resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, and group JK corynebacteria.
Topics: Actinomycetales; Cefotaxime; Ciprofloxacin; Gentamicins; Humans; Methicillin; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillin Resistance; Pseudomonas aeruginosa; Staphylococcus epidermidis; Ticarcillin; Vancomycin | 1986 |
Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
Topics: Acinetobacter; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Gentamicins; Haemophilus influenzae; Mezlocillin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus | 1985 |
Antibiotic treatment, intestinal aerobic microflora and experimental sarcoma L-1 growth in Balb/c-mice.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cell Division; Clindamycin; Enterobacteriaceae; Escherichia coli; Gentamicins; Intestines; Mezlocillin; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Piperacillin; Sarcoma, Experimental | 1987 |
In vitro microbiological properties of mezlocillin compared with four cephalosporins.
Topics: Bacteria; beta-Lactamases; Cefotaxime; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Hydrolysis; Mezlocillin; Microbial Sensitivity Tests; Mutation | 1986 |
In vitro antibacterial activity of mezlocillin against anaerobic bacteria.
Topics: Bacteria, Anaerobic; Cefotaxime; Cefoxitin; Mezlocillin; Microbial Sensitivity Tests | 1987 |
In vitro activity of pefloxacin.
Topics: Amikacin; Anti-Infective Agents; Cefotaxime; Ceftazidime; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance | 1986 |
Platelet-mediated bleeding caused by broad-spectrum penicillins.
Topics: Adult; Bleeding Time; Blood Platelet Disorders; Cefotaxime; Hemorrhage; Humans; Mezlocillin; Penicillins; Piperacillin; Prospective Studies; Ticarcillin | 1987 |
Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria.
Topics: Bacteria, Anaerobic; Cefotaxime; Cefoxitin; Ciprofloxacin; Drug Interactions; Drug Synergism; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; In Vitro Techniques; Metronidazole; Mezlocillin | 1987 |
Antibacterial activity of temocillin.
Topics: Cefazolin; Cefotaxime; Dose-Response Relationship, Drug; Enterobacteriaceae; In Vitro Techniques; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin | 1985 |
A survey of temocillin sensitivity of strains resistant to newer beta-lactam antibiotics.
Topics: Bacterial Infections; Cefotaxime; Humans; In Vitro Techniques; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin | 1985 |
Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a neutropenic site in rabbits.
Topics: Agranulocytosis; Amikacin; Animals; Cefotaxime; Ceftizoxime; Drug Combinations; Enterobacteriaceae; Female; Hydrogen-Ion Concentration; Kanamycin; Mezlocillin; Microbial Sensitivity Tests; Neutropenia; Rabbits | 1985 |
Beta-lactamase-positive strains of Haemophilus influenzae: susceptibility to and inactivation of beta-lactam antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefamandole; Cefoperazone; Cefotaxime; Ceftriaxone; Haemophilus influenzae; Mezlocillin; Microbial Sensitivity Tests; Moxalactam | 1985 |
Antibiotics and immunomodulation: effects of cefotaxime, amikacin, mezlocillin, piperacillin and clindamycin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Antibody Formation; Cefotaxime; Clindamycin; Hypersensitivity, Delayed; Immune System; Immunosuppressive Agents; In Vitro Techniques; Lymphocyte Activation; Male; Mezlocillin; Mice; Mice, Inbred BALB C; Piperacillin | 1985 |
Effects of cefotaxime, clindamycin, mezlocillin, and piperacillin on mouse sarcoma L-1 tumor.
Topics: Animals; Cefotaxime; Cell Line; Clindamycin; Cytotoxicity, Immunologic; Killer Cells, Natural; Lung Neoplasms; Male; Mezlocillin; Mice; Mice, Inbred BALB C; Piperacillin; Sarcoma, Experimental | 1984 |
Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Enterobacter; Enterobacteriaceae; Humans; Klebsiella pneumoniae; Mezlocillin; Mutation; Nalidixic Acid; Norfloxacin; Penicillin Resistance; Quinolines | 1984 |
In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
Topics: Azlocillin; beta-Lactamases; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Haemophilus influenzae; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins | 1980 |
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Cefsulodin; Cephalosporins; Dibekacin; Drug Synergism; Gentamicins; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1980 |
Comparative activity and beta-lactamase stability of carbenicillin, ticarcillin, azlocillin, mezlocillin and cefotaxime.
Topics: Azlocillin; beta-Lactamases; Carbenicillin; Cefotaxime; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Ticarcillin | 1981 |
[Bacteriological in vitro studies with a new cephalosporin: cefotiam (author's transl)].
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Cefotiam; Cefoxitin; Cefuroxime; Lactams; Mezlocillin; Microbial Sensitivity Tests; Penicillins | 1981 |
Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
Topics: Azlocillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Imipenem; Lactams; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin; Serratia marcescens | 1981 |
[In vitro susceptibility of Listeria monocytogenes with special reference to newer beta lactam antibiotics (author's transl)].
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Cephalosporins; Cephalothin; Doxycycline; Gentamicins; Listeria monocytogenes; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Piperacillin | 1981 |
[Chemotherapy of listeriosis (author's transl)].
Topics: Ampicillin; Cefamandole; Cefotaxime; Cefoxitin; Cefuroxime; Doxycycline; Gentamicins; Humans; Listeriosis; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Piperacillin | 1982 |
The new cephalosporins and penicillins.
Topics: Azlocillin; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Mezlocillin; Moxalactam; Penicillins; Piperacillin | 1982 |
Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam.
Topics: Anti-Bacterial Agents; Azlocillin; Bacteria; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Drug Synergism; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillins | 1982 |
[Antibiotic treatment of human actinomykoses (author's transl)].
Topics: Actinomycosis; Ampicillin; Cefotaxime; Cefoxitin; Clindamycin; Metronidazole; Mezlocillin; Microbial Sensitivity Tests; Minocycline; Penicillin G; Penicillins | 1982 |
Agar (disk) diffusion test susceptibility of clinical isolates of Pseudomonas aeruginosa to azlocillin, cefotaxime, cefsulodin, lamoxactam, mezlocillin, and piperacillin.
Topics: Azlocillin; Cefotaxime; Cefsulodin; Cephalosporins; Cephamycins; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1982 |
Combination of ceftizoxime with azlocillin, mezlocillin, piperacillin and ticarcillin.
Topics: Azlocillin; Bacteria; Cefotaxime; Ceftizoxime; Drug Interactions; Enterobacteriaceae; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas; Ticarcillin | 1982 |
[Comparative activity of azlocillin on Pseudomonas species excluding Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Cefsulodin; Cephalosporins; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas; Pseudomonas fluorescens | 1984 |
Measurement of levels of aminoglycosides and vancomycin in serum in the presence of new beta-lactam antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Humans; Immunoenzyme Techniques; Mezlocillin; Moxalactam; Penicillins; Piperacillin; Vancomycin | 1984 |
Influence of ciprofloxacin and other antimicrobial drugs on different Escherichia coli strains in continuous-flow cultures under aerobic and anaerobic conditions.
Topics: Aerobiosis; Anaerobiosis; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Culture Media; Escherichia coli; Feces; Gentamicins; Mezlocillin; Penicillins | 1998 |